Haemonetics HAE
NYSE HAE
$100.90 -2.26 (-2.19%)
As of: Sep 10, 2026 · 3:26 PM EDT

Haemonetics (HAE) Gross Profit Growth (1y) (2010 - 2026)

Analysis

Haemonetics (HAE) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Abbott Laboratories 180.08 Bn 174.48 Bn 7.27 Bn 15.59%
2 Intuitive Surgical 127.86 Bn 122.64 Bn 1.96 Bn 21.17%
3 Medtronic 117.15 Bn 108.33 Bn 6.34 Bn 13.68%
4 Stryker 103.82 Bn 100.34 Bn 4.50 Bn 17.10%
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 12.38%
6 Edwards Lifesciences 49.76 Bn 45.51 Bn 1.35 Bn 13.54%
7 Alcon 32.95 Bn 31.49 Bn 1.68 Bn 20.68%
8 Dexcom 32.22 Bn 30.27 Bn 830.00 Mn 20.50%
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn 8.95%
10 Haemonetics 4.58 Bn 4.36 Bn 202.80 Mn 5.49%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 5.49%
Mar 28, 2026 2.67%
Dec 27, 2025 4.57%
Sep 27, 2025 3.90%
Jun 28, 2025 9.90%
Mar 29, 2025 9.75%
Dec 28, 2024 8.82%
Sep 28, 2024 9.93%
Jun 29, 2024 4.58%
Mar 30, 2024 12.58%
Dec 30, 2023 12.07%
Sep 30, 2023 8.00%
Jul 1, 2023 17.57%
Apr 1, 2023 14.63%
Dec 31, 2022 14.54%
Oct 1, 2022 28.84%
Jul 2, 2022 31.62%
Apr 2, 2022 66.63%
Jan 1, 2022 15.22%
Oct 2, 2021 15.88%